Topics

Articles

Biopharma companies are investing in field reimbursement staff to reduce patient barriers to therapy by guiding prescribing physicians through specialty therapy access and adherence challenges

More Than Ever, New Therapies Require Reimbursement Support

Company pitches a mfr-payer-provider-patient collaboration for drug pricing

Kalderos’ 340b management tools will broaden with new funding

Trinity Life Sciences offers a way to measure changing physician practices during the pandemic

Get a flash reading of physician sentiment with COVIDPulse

Extension of the company’s Pathways program seeks to offer a richer and deeper patient interaction

UBC offers ‘intelligent mobile messaging’ in patient support programs

Position highlights the move toward more at-home services

CMS should reimburse community pharmacists for at-home drug delivery, says NCPA

Use of an eBV system can save months of re-verification work and >$100,000 in operational costs

Planning for the surge: Taking a proactive approach to benefits re-verification season

Pharma marketing will have to adjust to a new reality

The impact of Covid-19 across market access stakeholders and what it means for manufacturers

The PBMs’ new trend toward controlling the flow of funds for patient support is raising questions

Copay maximizers have murky financial implications, says Drug Channels

Reasons for, and actions to take, when switching hub service providers

How to successfully transition patient solutions providers

Acquisition of Cumberland Life Sciences boosts its client base and range of services

Commercial Channels